Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery Article

Gilbert, Mark R, Kuhn, John, Lamborn, Kathleen R et al. (2012). Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery . JOURNAL OF NEURO-ONCOLOGY, 106(1), 147-153. 10.1007/s11060-011-0650-1

Open Access

cited authors

  • Gilbert, Mark R; Kuhn, John; Lamborn, Kathleen R; Lieberman, Frank; Wen, Patrick Y; Mehta, Minesh; Cloughesy, Timothy; Lassman, Andrew B; DeAngelis, Lisa M; Chang, Susan; Prados, Michael

sustainable development goals

authors

publication date

  • January 1, 2012

published in

keywords

  • ALPHA(V)BETA(3)
  • ALPHA-V-BETA-3
  • ANGIOGENESIS
  • BRAIN-TUMORS
  • Clinical Neurology
  • EMD-121974
  • EXPRESSION
  • Glioblastoma
  • INTEGRIN
  • Integrins
  • Life Sciences & Biomedicine
  • MALIGNANT GLIOMAS
  • MECHANISMS
  • Neurosciences & Neurology
  • Oncology
  • PATTERNS
  • Pharmacokinetics
  • Science & Technology
  • Tumor pharmacokinetics

Digital Object Identifier (DOI)

publisher

  • SPRINGER

start page

  • 147

end page

  • 153

volume

  • 106

issue

  • 1